AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
Apr 23, 2013
30583_dirs_2013-04-23_1637d347-228e-457e-b65c-1c5a97cdcf2f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-04-22
Reporting Person: Wood Mark (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-22 | Common Stock | M | 937 | $14.39 | Acquired | 24182 | Direct |
| 2013-04-22 | Common Stock | M | 833 | $21.51 | Acquired | 25015 | Direct |
| 2013-04-22 | Common Stock | M | 812 | $26.49 | Acquired | 25827 | Direct |
| 2013-04-22 | Common Stock | M | 520 | $37.46 | Acquired | 26347 | Direct |
| 2013-04-22 | Common Stock | S | 3102 | $65.5748 | Disposed | 23245 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-04-22 | Stock Option (right to buy) Common Stock | $14.39 | M | 937 | Disposed | 2019-05-11 | Common Stock (937) | Direct |
| 2013-04-22 | Stock Option (right to buy) Common Stock | $21.51 | M | 833 | Disposed | 2020-05-11 | Common Stock (833) | Direct |
| 2013-04-22 | Stock Option (right to buy) | $26.49 | M | 812 | Disposed | 2021-05-11 | Common Stock (812) | Direct |
| 2013-04-22 | Stock Option (right to buy) Common Stock | $37.46 | M | 520 | Disposed | 2022-05-07 | Common Stock (520) | Direct |
Footnotes
F1: Transaction made pursuant to a Rule 10b5-1 plan executed on August 13, 2012.
F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $65.01 to $66.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.
F4: Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter.
Remarks:
F5: Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter.
F6: Original option grant vests 6/48th on November 8, 2012 and 1/48th each on the 8th of each month thereafter.
F7: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.